From Medscape Neurology

Coverage from the

American Academy of Neurology 2017 Annual Meeting (AAN)

April 22 - 28, 2017; Boston, Massachusetts

April 22 - 28, 2017 Boston, Massachusetts
  • AAN Phase 3 Trials Positive for Erenumab in Migraine Prevention Both STRIVE and ARISE phase 3 trials met their primary outcomes, showing greater reductions in monthly migraine days for patients with episodic migraine treated with erenumab vs those receiving placebo.
  • Even Mildly Insufficient Sleep Linked to Depression Getting 6 hours of sleep per night, just 1 less than 'optimum sleep duration,' was associated with 60% to 80% greater risk for depression, hopelessness, and nervousness, report investigators.
  • New AAN/AES Guideline on SUDEP The American Academy of Neurology has released a new guideline on incidence rates of and risk factors for sudden unexpected death in patients with epilepsy.

Conference News

Popular News from AAN 2016

Medscape Neurology©  WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Perspectives

 

Previous Coverage